Redeye endorses ISAB signing yet another IRS contract worth around SEK 773,000 (EUR 74,000). The contract is for a research project with a leading Swiss developer of inhaled generics. We are encouraged by the continued high activity in the IRS segment and retain our long-term positive view of ISAB.

Link to the analysis